Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease
Takeo Naito(Cedars-Sinai Medical Center), Dermot McGovern(Salford Royal NHS Foundation Trust), Judy H. Cho(Cedars-Sinai Medical Center), Talin Haritunians(Cedars-Sinai Medical Center), Steven R. Brant(Rutgers, The State University of New Jersey), Richard H. Duerr(University of Pittsburgh), Christine Stevens(Broad Institute), Jonathan Braun(Cedars-Sinai Medical Center), Emebet Mengesha(Cedars-Sinai Medical Center), Atsushi Masamune(Tohoku University), Gregory J. Botwin(Cedars-Sinai Medical Center), Lisa Abbou(Cedars-Sinai Medical Center), L. Philip Schumm(Chicago Department of Public Health), John D. Rioux(Institute for Molecular Medicine Finland), Michelle Khrom(Cedars-Sinai Medical Center), Dalin Li(Cedars-Sinai Medical Center), Mark S. Silverberg(Sinai Health System), Mark J. Daly(Broad Institute), Shaohong Yang(Cedars-Sinai Medical Center)
Cited by 16
Related Papers
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Biological insights from 108 schizophrenia-associated genetic loci
|Nature|2014|8.1k